Zosyn® (piperacillin/tazobactam) reformulation: Expanded compatibility and coadministration with lactated Ringer's solutions and selected aminoslycosides

Therapeutics and Clinical Risk Management

Volumn 4, Issue 2, 2008, Pages 303-314

  Desai, Narendra R ^a   Shah, Syed M ^a   Cohen, Jonathan ^a   McLaughlin, Matthew ^a   Dalal, Hema R ^a  

^a WYETH RESEARCH   (United States)

Author keywords

Aminoglycoside; Particulate matter; Piperacillin; Zosyn

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; CITRATE SODIUM; DRUG; EDETATE DISODIUM; GENTAMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RINGER LACTATE SOLUTION; ZINC OXIDE;

ABDOMINAL INFECTION; COMMUNITY ACQUIRED PNEUMONIA; CRITICAL ILLNESS; DRUG APPROVAL; DRUG CONCENTRATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DOSAGE FORM; DRUG DOSE COMPARISON; DRUG FORMULATION; DRUG INCOMPATIBILITY; DRUG INDICATION; DRUG LABELING; DRUG MANUFACTURE; DRUG MEGADOSE; DRUG MIXTURE; DRUG PACKAGING; DRUG POTENCY; DRUG SCREENING; DRUG STABILITY; DRUG STRUCTURE; HOSPITAL INFECTION; HUMAN; LEACHING; LOW DRUG DOSE; NUCLEAR MAGNETIC RESONANCE; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION;

EID: 44049095124     PISSN: 11766336     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Bandoh K, Katoh M, Muto Y, et al. 1991. Metal induced degradation of β-lactams. Chemotherapy, 39:315-8.
2. Benveniste R, Davis J. 1973. Structure activity relationships among the aminoglycoside antibiotics: role of hydroxyl and amino groups. Antimicrob Agents Chemother, 4:402-9.
3. Choi JS, Burm JP, Jhee SS, et al. 1994. Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration. Am J Hosp Pharm, 51:2273-6.
4. Desai NR, Vencl-Joncic M, Koczone K, et al. 2007a. Screening of Zinc in commercial intravenous diluents commonly used for reconstitution and admixing of injectable dosage forms, and flushing of administration devices [poster]. Am Pharm Assoc Ann Meet (Atlanta, GA), 167.
5. Desai NR, Shah SM, Koczone K, et al. 2007b. Zinc content of commercial diluents widely used in drug admixtures prepared for intravenous infusion. Int J Pharma Compound, 11:4226-432.
6. European Pharmacopeia. 2004. Particulate contamination: Subvisible particles. 5.0(2004)2.9.19, pp. 253-5.
7. Falchuk KH, Peterson L, McNeal J. 1985. Microparticulate induced phlebitis: Its prevention by in-line filtration. N Eng J Med, 312:78-82.
8. Glew RH, Pavuk R. 1983. Stability of gentamicin, tobramicin and amikacin in combination with four β-lactam antibiotics. Antimicrob Agents Chemother, 24:474-7.
9. Jenke DR. 2005. Linking extractables and leachables in container/closure applications. DA J Pharm Sci Technol, 59:265-81.
10. Lehr H-A, Brunner J, Rangoonwala Ret al. 2002. Particulate matter contamination of intravenous antibiotics aggravates loss of functional capillary density in post ischemic striated muscle. Am J Respir Crit Care Med, 165:514-20.
11. Leissing NC, Story KO, Zaske D. 1989. Inline fluid dynamics in piggyback and manifold drug delivery systems, Am J Hosp Pharm, 46:89-97.
12. Longe RL. 1980. Particulate contamination in selected parenteral drugs. Can Anesthesic Soc J, 27:62-4.
13. Nath N, McNeal E, Obenhuber D, et al. 2004. Particulate contaminants of intravenous medication and the limits set by USP General Chapter <788>. Pharmacopeial Forum, 30:2272-80.
14. Trissel LA, Martinez JF. 1994a. Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection. Am J Hosp Pharm, 51:672-8.
15. Trissel LA, 1994b. Handbook of Injectable Drugs, PP XVIII, 5th Edition, American Society of Health-System Pharmacists® Bethesda, MD, USA.
16. [USP] United States Pharmacopeia. 2007. USP 30, Supplement 2. <788>, Particulate matter in injections.
17. Winter W, Deubner R, Holzgrabe U. 2005. Multivariate analysis of nuclear magnetic resonance data-characterization of critical drug substance quality of gentamicin sulfate. J Pharm Biomed Anal. 38:833-9.
18. Wyeth Pharmaceuticals. 2007a. Zosyn® (Piperacillin/Tazobactam For Injection USP [Glass Vials]) United States Prescribing Information.
19. Wyeth Pharmaceuticals. 2007b. Zosyn® (Piperacillin/Tazobactam For Injection USP [Galaxy® Bags]) United States Prescribing Information.